-
Mid-Day Market Update: VOXX International Jumps Following Q3 Earnings; RedHill Biopharma Shares Slide
12 Jan 2021 17:37 GMT
… after the company priced its IPO at $5 per share.
Shares … .25 per unit.
Shares of RedHill Biopharma Ltd. (NASDAQ: RDHL) were down …
-
Revisiting RedHill Biopharma
05 Jan 2020 13:03 GMT
… the paragraphs below. Company Overview RedHill Biopharma (RDHL) is an Israeli drug … for the Biotech Forum, Busted IPO Forum, and Insiders Forum.
I …
-
AN2 Therapeutics Files For U.S. IPO
08 Mar 2022 19:08 GMT
… related treatments include: Insmed RedHill Biopharma novoteris Savara Beyond Air Spero … total liabilities. AN2 Therapeutics IPO Details AN2 intends to … . Listed bookrunners of the IPO are Cowen, SVB Leerink, … the lead underwriter and IPOs led by the firm …
-
The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
01 Oct 2021 12:43 GMT
… )
Pliant Therapeutics, Inc. (NASDAQ: PLRX)
RedHill Biopharma Ltd. (NASDAQ: RDHL)
RenovoRx, Inc … Phase 3 study of AZD1222
IPOs
Exscientia plc (NASDAQ: EXAI), an … pharmatech company, priced its upsized initial public offering of 13.85 million ADSs …
-
The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs
15 Sep 2021 11:54 GMT
… N.V. (NASDAQ: PHAR)
RedHill Biopharma Ltd. (NASDAQ: RDHL) (announced … IPOs
Procept Biorobotics Corporation (NASDAQ: PRCT) priced its upsized initial public offering … , priced its upsized IPO of 10.8 million … disorders, priced its upsized IPO of 4.8 million …
-
The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs
30 Jul 2021 12:43 GMT
… 48% at $68.80.
Offerings
RedHill Biopharma Ltd. (NASDAQ: RDHL) … ) (before the market open)
IPOs
Immuneering Corporation (NASDAQ: IMRX), … dynamics, priced its upsized initial public offering of 7.5 million … technologies, priced its upsized IPO of 13.5 million …
-
The Daily Biotech Pulse: Vir-GlaxoSmithKline COVID-19 Antibody Treatment Approved, Zosano Spikes On Long-term Migraine Drug Data, Decision Day For Eton, 2 IPOs
27 May 2021 12:30 GMT
… ) (before the market open)
RedHill Biopharma Ltd. (NASDAQ: RDHL) (before … ASND) (after the close)
IPOs
Day One Biopharmaceuticals, Inc., a … defined cancers, priced its initial public offering of 10 million shares … medicine, priced its upsized IPO of 10.2 million …
-
The Daily Biotech Pulse: Novavax Vaccine Readout, Clinical Hold On Bellicum Study Lifted, Lilly Earnings, NLS Pharma IPO
29 Jan 2021 14:05 GMT
… 10.55% to $2.20.
Redhill Biopharma Given Nod to Proceed With … -19 Study Following Futility Analysis
RedHill Biopharma Ltd (NASDAQ: RDHL) said the … estimates)
IPOs
Switzerland-based NLS Pharmaceutics Ltd. priced its initial public offering of 4 …
-
The Daily Biotech Pulse: Moderna Inks 2 R&D Deals, BioNTech To Buy Manufacturing Facility, Dyne Therapeutics IPO
17 Sep 2020 12:59 GMT
… Therapeutics Inc (NASDAQ: PTGX)
RedHill Biopharma Ltd (NASDAQ: RDHL)
Revance Therapeutics … Day For Bausch Health, IPO Flow Resumes, Oncology Conference
… IPOs
Waltham, Massachusetts-based Dyne Therapeutics, Inc. priced its upsized initial public offering …
-
RedHill Biopharma Announces Appointment of Micha Ben Chorin as Chief Financial Officer
30 Dec 2015 13:00 GMT
… 2015 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ:RDHL) … preparations for its successful IPO. Most recently, Mr … RedHill team.” About RedHill Biopharma Ltd.:
RedHill Biopharma Ltd. (NASDAQ:RDHL … Development &
Licensing
RedHill Biopharma
+972-54-6543- …
About
© 1995-2025